ZA931444B - Pulsatile once-a-day-delivery systems for minocycline - Google Patents

Pulsatile once-a-day-delivery systems for minocycline

Info

Publication number: ZA931444B
Authority: ZA; South Africa
Prior art keywords: minocycline; release; day; systems; delivery systems
Prior art date: 1992-03-02

Application number

ZA931444A

Other languages

English (en)

Inventor

Nitin Vadilal Sheth

Joseph James Valorose Jr

Keith Anthony Ellway

Madurai Gurusamy Ganesan

Keiran George Mooney

Jerry Bain Johnson

Original Assignee

American Cyanamid Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-03-02

Filing date

1993-03-01

Publication date

1993-10-14

1993-03-01 Application filed by American Cyanamid Co filed Critical American Cyanamid Co

1993-10-14 Publication of ZA931444B publication Critical patent/ZA931444B/xx

Links

DYKFCLLONBREIL-KVUCHLLUSA-N minocycline Chemical compound C([C@H]1C2)C3=C(N(C)C)C=CC(O)=C3C(=O)C1=C(O)[C@@]1(O)[C@@H]2[C@H](N(C)C)C(O)=C(C(N)=O)C1=O DYKFCLLONBREIL-KVUCHLLUSA-N 0.000 title abstract 4
229960004023 minocycline Drugs 0.000 title abstract 4
230000000541 pulsatile effect Effects 0.000 title 1
239000000203 mixture Substances 0.000 abstract 3
238000009472 formulation Methods 0.000 abstract 2
239000008187 granular material Substances 0.000 abstract 2
RMVMLZHPWMTQGK-SOUFLCLCSA-N (4s,4as,5as,6s,12ar)-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-3,12-dioxo-4a,5,5a,6-tetrahydro-4h-tetracene-2-carboxamide Chemical compound C1([C@H]2O)=CC=CC(O)=C1C(O)=C1[C@@H]2C[C@H]2[C@H](N(C)C)C(=O)C(C(N)=O)=C(O)[C@@]2(O)C1=O RMVMLZHPWMTQGK-SOUFLCLCSA-N 0.000 abstract 1
239000002253 acid Substances 0.000 abstract 1
230000036765 blood level Effects 0.000 abstract 1
239000002775 capsule Substances 0.000 abstract 1
JCSGAUKCDAVARS-UHFFFAOYSA-N demethyltetracycline Natural products CN(C1C(=C(C(C2(C(=C3C(C4=C(C=CC=C4C(C3CC12)O)O)=O)O)O)=O)C(=O)N)O)C JCSGAUKCDAVARS-UHFFFAOYSA-N 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
231100000252 nontoxic Toxicity 0.000 abstract 1
230000003000 nontoxic effect Effects 0.000 abstract 1
229920000642 polymer Polymers 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
230000001225 therapeutic effect Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/65—Tetracyclines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Oncology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Communicable Diseases (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Electrotherapy Devices (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicines Containing Plant Substances (AREA)
Investigating Or Analysing Biological Materials (AREA)
Magnetic Resonance Imaging Apparatus (AREA)
Magnetic Treatment Devices (AREA)
Laser Surgery Devices (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Management, Administration, Business Operations System, And Electronic Commerce (AREA)
Position Fixing By Use Of Radio Waves (AREA)
Physical Deposition Of Substances That Are Components Of Semiconductor Devices (AREA)

ZA931444A 1992-03-02 1993-03-01 Pulsatile once-a-day-delivery systems for minocycline ZA931444B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US07/844,109 US5262173A (en)	1992-03-02	1992-03-02	Pulsatile once-a-day delivery systems for minocycline

Publications (1)

Publication Number	Publication Date
ZA931444B true ZA931444B (en)	1993-10-14

Family

ID=25291839

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA931444A ZA931444B (en)	1992-03-02	1993-03-01	Pulsatile once-a-day-delivery systems for minocycline

Country Status (25)

Country	Link
US (2)	US5262173A (xx)
EP (1)	EP0558913B1 (xx)
JP (1)	JPH069407A (xx)
KR (1)	KR100270491B1 (xx)
CN (1)	CN1039194C (xx)
AT (1)	ATE181504T1 (xx)
AU (1)	AU656841B2 (xx)
CA (1)	CA2090561C (xx)
CZ (1)	CZ283684B6 (xx)
DE (1)	DE69325402T2 (xx)
DK (1)	DK0558913T3 (xx)
ES (1)	ES2134221T3 (xx)
FI (1)	FI110163B (xx)
GR (1)	GR3031028T3 (xx)
HK (1)	HK1009930A1 (xx)
HU (1)	HU219580B (xx)
IL (1)	IL104865A (xx)
LV (1)	LV12399B (xx)
MX (1)	MX9300998A (xx)
NO (1)	NO307170B1 (xx)
NZ (1)	NZ245951A (xx)
PL (1)	PL171609B1 (xx)
SG (1)	SG47785A1 (xx)
TW (1)	TW299235B (xx)
ZA (1)	ZA931444B (xx)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE4031881C2 (de) *	1990-10-08	1994-02-24	Sanol Arznei Schwarz Gmbh	Lösungsmittelfreie, oral zu verabreichende pharmazeutische Zubereitung mit verzögerter Wirkstoffreisetzung und Verfahren zu deren Herstellung
WO1996010996A1 (en) *	1993-07-21	1996-04-18	The University Of Kentucky Research Foundation	A multicompartment hard capsule with control release properties
US5538737A (en) *	1994-11-30	1996-07-23	Applied Analytical Industries, Inc.	Oral compositions of H2 -antagonists
GB9518465D0 (en) *	1995-09-09	1995-11-08	Smithkline Beecham Seiyaku Kk	Pharmaceuticals
ZA974359B (en) *	1996-05-23	1998-05-12	Zeneca Ltd	Microencapsulated compositions.
US5932437A (en) *	1998-04-13	1999-08-03	Genesis Laboratories, Inc.	Control of lyme disease spirochete
CN1406126A (zh) *	1998-10-01	2003-03-26	诺瓦提斯公司	新型缓释口服制剂
JP2000119181A (ja)	1998-10-06	2000-04-25	Kureha Chem Ind Co Ltd	エスクレチン及びその誘導体の放出制御経口製剤
AU770645B2 (en) *	1998-11-02	2004-02-26	Alkermes Pharma Ireland Limited	Multiparticulate modified release composition
US20060240105A1 (en) *	1998-11-02	2006-10-26	Elan Corporation, Plc	Multiparticulate modified release composition
US20090149479A1 (en) *	1998-11-02	2009-06-11	Elan Pharma International Limited	Dosing regimen
US6432448B1 (en)	1999-02-08	2002-08-13	Fmc Corporation	Edible coating composition
US6723342B1 (en)	1999-02-08	2004-04-20	Fmc Corporation	Edible coating composition
US7691831B2 (en) *	1999-03-17	2010-04-06	Ernest L. Bonner, Jr.	Pharmaceutical combination and method for treatment of reactive arthritis or bursitis
US7884090B2 (en) *	1999-03-17	2011-02-08	Ernest L. Bonner, Jr.	Compositions and methods for the treatment of arthritis
US20050137181A1 (en) *	1999-03-17	2005-06-23	Bonner Ernest L.	Method for treatment of reactive arthritis or bursitis
US6765000B2 (en) *	1999-03-17	2004-07-20	Bonner Jr Ernest L	Treatment for reactive arthritis or bursitis
US20030170181A1 (en) *	1999-04-06	2003-09-11	Midha Kamal K.	Method for preventing abuse of methylphenidate
CA2366791A1 (en)	1999-04-06	2000-10-12	Kamal K. Midha	Pharmaceutical dosage form for pulsatile delivery of d-threo-methylphenidate and a second cns stimulant
US6500462B1 (en)	1999-10-29	2002-12-31	Fmc Corporation	Edible MCC/PGA coating composition
CA2389235C (en)	1999-10-29	2007-07-17	Euro-Celtique, S.A.	Controlled release hydrocodone formulations
US10179130B2 (en)	1999-10-29	2019-01-15	Purdue Pharma L.P.	Controlled release hydrocodone formulations
IL149282A (en) *	1999-10-29	2010-05-31	Fmc Corp	Edible coating composition
KR101167465B1 (ko)	2000-10-30	2012-07-27	유로-셀티크 소시에떼 아노뉨	서방성 하이드로코돈 제형
IL155959A0 (en)	2000-11-28	2003-12-23	Fmc Corp	Edible pga (propylene glycol alginate) coating composition
CA2447008A1 (en) *	2001-04-05	2002-10-24	Collagenex Pharmaceuticals, Inc.	Controlled delivery of tetracycline compounds and tetracycline derivatives
US20040137061A1 (en) *	2001-06-07	2004-07-15	Takashi Ishibashi	Functional grain-containing preparations quickly disintegrated in the oral cavity
US6958161B2 (en)	2002-04-12	2005-10-25	F H Faulding & Co Limited	Modified release coated drug preparation
JP4427453B2 (ja)	2002-12-20	2010-03-10	エフ．ホフマン−ラロシュアーゲー	高用量イバンドロネート製剤
PT1615622E (pt)	2003-04-07	2012-10-17	Supernus Pharmaceuticals Inc	Formulações de doxiciclinas de dose única diária
GB2414668B (en) *	2004-06-03	2009-07-29	Dexcel Ltd	Tetracycline modified release delivery system
US8461187B2 (en)	2004-06-16	2013-06-11	Takeda Pharmaceuticals U.S.A., Inc.	Multiple PPI dosage form
US20060121112A1 (en) *	2004-12-08	2006-06-08	Elan Corporation, Plc	Topiramate pharmaceutical composition
WO2006110807A1 (en) *	2005-04-12	2006-10-19	Elan Pharma International Limited	Controlled release compositions comprising a cephalosporin for the treatment of a bacterial infection
US7919483B2 (en) *	2005-06-24	2011-04-05	Medicis Pharmaceutical Corporation	Method for the treatment of acne
US7544373B2 (en) *	2007-04-02	2009-06-09	Medicis Pharmaceutical Corporation	Minocycline oral dosage forms for the treatment of acne
US7541347B2 (en) *	2007-04-02	2009-06-02	Medicis Pharmaceutical Coropration	Minocycline oral dosage forms for the treatment of acne
US8252776B2 (en)	2007-04-02	2012-08-28	Medicis Pharmaceutical Corporation	Minocycline oral dosage forms for the treatment of acne
US8722650B1 (en)	2005-06-24	2014-05-13	Medicis Pharmaceutical Corporation	Extended-release minocycline dosage forms
US20080242642A1 (en) *	2007-04-02	2008-10-02	Medicis Pharmaceutical Corporation	Minocycline oral dosage forms for the treatment of acne
US20080241235A1 (en) *	2007-04-02	2008-10-02	Medicis Pharmaceutical Corporation	Minocycline oral dosage forms for the treatment of acne
WO2007038867A1 (en) *	2005-10-04	2007-04-12	Mistral Pharma Inc.	Controlled-release oral dosage form
US20070166273A1 (en) *	2006-01-19	2007-07-19	Krivulka Joseph J	Skin treatment educational kit
PT103661B (pt) *	2007-02-23	2010-09-07	Hovione Farmaciencia S A	Processo de preparação de minociclina base cristalina
JP2010521494A (ja) *	2007-03-16	2010-06-24	エラン・ファルマ・インターナショナル・リミテッド	麻薬性および非麻薬性鎮痛剤の組み合わせ
US20080241197A1 (en) *	2007-04-02	2008-10-02	Medicis Pharmaceutical Corporation	Minocycline dosage forms for the treatment of acne
MY153062A (en)	2007-10-12	2014-12-31	Takeda Pharmaceuticals Usa Inc	Methods of treating gastrointestinal disorders independent of the intake of food
WO2010017310A1 (en)	2008-08-06	2010-02-11	Medicis Pharmaceutical Corporation	Method for the treatment of acne and certain dosage forms thereof
EP2699236B1 (en)	2011-04-22	2018-06-20	Napo Pharmaceuticals Inc	Pharmacologically optimized multimodal drug delivery system for nordihydroguiaretic acid (ndga)
EP2704698B1 (de)	2011-05-05	2019-10-02	Hennig Arzneimittel GmbH&Co. Kg	Arzneiform zur gezielten freigabe von wirkstoffen
DE102011075354A1 (de) *	2011-05-05	2012-11-08	Hennig Arzneimittel Gmbh & Co. Kg	Arzneiform zur gezielten Freigabe von Wirkstoffen
US9561241B1 (en)	2011-06-28	2017-02-07	Medicis Pharmaceutical Corporation	Gastroretentive dosage forms for minocycline
US11103517B2 (en)	2015-04-07	2021-08-31	Dr. Reddy's Laboratories Ltd.	Pharmaceutical compositions for minocycline
CN108414466A (zh) *	2018-03-09	2018-08-17	浙江美华鼎昌医药科技有限公司	一种盐酸米诺环素缓释片体外溶出测定方法
CN112584827A (zh) *	2018-04-30	2021-03-30	梅琳塔治疗公司	用米诺环素治疗细菌感染的方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NL270408A (xx) *	1960-10-20
US3865935A (en) *	1972-08-10	1975-02-11	Abbott Lab	Tableting of erythromycin base
US4250166A (en) *	1977-05-27	1981-02-10	Shionogi & Co., Ltd.	Long acting preparation of cefalexin for effective treatments of bacterial infection sensitive to cefalexin
GB1561204A (en) *	1977-06-01	1980-02-13	Ici Ltd	Sustained release pharmaceutical composition
US4173626A (en) *	1978-12-11	1979-11-06	Merck & Co., Inc.	Sustained release indomethacin
FR2447192A1 (fr) *	1979-01-25	1980-08-22	Adria Lab Inc	Forme galenique a liberation prolongee d'indoprofene
US4353887A (en) *	1979-08-16	1982-10-12	Ciba-Geigy Corporation	Divisible tablet having controlled and delayed release of the active substance
DK150008C (da) *	1981-11-20	1987-05-25	Benzon As Alfred	Fremgangsmaade til fremstilling af et farmaceutisk oralt polydepotpraeparat
JPS61210025A (ja) *	1985-03-14	1986-09-18	Teisan Seiyaku Kk	安定化された抗生物質複合顆粒製剤
GB8521494D0 (en) *	1985-08-29	1985-10-02	Zyma Sa	Controlled release tablet
US4808413A (en) *	1987-04-28	1989-02-28	E. R. Squibb & Sons, Inc.	Pharmaceutical compositions in the form of beadlets and method
US4837030A (en) *	1987-10-06	1989-06-06	American Cyanamid Company	Novel controlled release formulations of tetracycline compounds
EP0327295A3 (en) *	1988-02-01	1989-09-06	F.H. FAULDING & CO. LTD.	Tetracycline dosage form
US5133974A (en) *	1989-05-05	1992-07-28	Kv Pharmaceutical Company	Extended release pharmaceutical formulations
ATE114472T1 (de) *	1989-09-21	1994-12-15	American Cyanamid Co	System des typs ''einmal täglich'' zur gepulsten minocyclinabgabe.
EP0418596A3 (en) *	1989-09-21	1991-10-23	American Cyanamid Company	Controlled release pharmaceutical compositions from spherical granules in tabletted oral dosage unit form
IT1241417B (it) *	1990-03-06	1994-01-14	Vectorpharma Int	Composizioni terapeutiche a rilascio controllato di farmaci supportatisu polimeri reticolati e rivestiti con film polimerici,e loro processodi preparazione
US5286497A (en) *	1991-05-20	1994-02-15	Carderm Capital L.P.	Diltiazem formulation

1992
- 1992-03-02 US US07/844,109 patent/US5262173A/en not_active Expired - Lifetime
1993
- 1993-01-25 DK DK93101096T patent/DK0558913T3/da active
- 1993-01-25 SG SG1996004364A patent/SG47785A1/en unknown
- 1993-01-25 ES ES93101096T patent/ES2134221T3/es not_active Expired - Lifetime
- 1993-01-25 AT AT93101096T patent/ATE181504T1/de not_active IP Right Cessation
- 1993-01-25 EP EP93101096A patent/EP0558913B1/en not_active Expired - Lifetime
- 1993-01-25 DE DE69325402T patent/DE69325402T2/de not_active Expired - Lifetime
- 1993-02-22 NZ NZ245951A patent/NZ245951A/en not_active IP Right Cessation
- 1993-02-24 MX MX9300998A patent/MX9300998A/es unknown
- 1993-02-25 CN CN93101947A patent/CN1039194C/zh not_active Expired - Lifetime
- 1993-02-25 IL IL10486593A patent/IL104865A/xx not_active IP Right Cessation
- 1993-02-26 AU AU33842/93A patent/AU656841B2/en not_active Expired
- 1993-02-26 CA CA002090561A patent/CA2090561C/en not_active Expired - Lifetime
- 1993-02-27 KR KR1019930002984A patent/KR100270491B1/ko not_active IP Right Cessation
- 1993-03-01 JP JP5062500A patent/JPH069407A/ja active Pending
- 1993-03-01 PL PL93297903A patent/PL171609B1/pl unknown
- 1993-03-01 FI FI930906A patent/FI110163B/fi not_active IP Right Cessation
- 1993-03-01 ZA ZA931444A patent/ZA931444B/xx unknown
- 1993-03-01 NO NO930743A patent/NO307170B1/no not_active IP Right Cessation
- 1993-03-01 HU HU9300570A patent/HU219580B/hu not_active IP Right Cessation
- 1993-03-01 CZ CZ93300A patent/CZ283684B6/cs not_active IP Right Cessation
- 1993-04-02 TW TW082102503A patent/TW299235B/zh active
- 1993-06-23 US US08/081,632 patent/US5348748A/en not_active Expired - Lifetime
1998
- 1998-09-10 HK HK98110557A patent/HK1009930A1/xx not_active IP Right Cessation
1999
- 1999-08-18 GR GR990402106T patent/GR3031028T3/el unknown
- 1999-09-16 LV LVP-99-133A patent/LV12399B/en unknown

Also Published As

Publication number	Publication date
FI110163B (fi)	2002-12-13
PL297903A1 (en)	1993-11-15
CZ283684B6 (cs)	1998-06-17
JPH069407A (ja)	1994-01-18
NO307170B1 (no)	2000-02-21
NO930743D0 (no)	1993-03-01
LV12399A (lv)	1999-12-20
HUT64851A (en)	1994-03-28
SG47785A1 (en)	1998-04-17
MX9300998A (es)	1993-09-01
IL104865A0 (en)	1993-06-10
CN1039194C (zh)	1998-07-22
ES2134221T3 (es)	1999-10-01
HU219580B (hu)	2001-05-28
GR3031028T3 (en)	1999-12-31
EP0558913A1 (en)	1993-09-08
CN1078889A (zh)	1993-12-01
TW299235B (xx)	1997-03-01
AU656841B2 (en)	1995-02-16
US5348748A (en)	1994-09-20
CA2090561C (en)	2004-10-05
CZ30093A3 (en)	1994-02-16
ATE181504T1 (de)	1999-07-15
NZ245951A (en)	1994-06-27
AU3384293A (en)	1993-09-09
PL171609B1 (pl)	1997-05-30
DE69325402T2 (de)	2000-02-17
KR100270491B1 (ko)	2000-11-01
EP0558913B1 (en)	1999-06-23
FI930906A0 (fi)	1993-03-01
HU9300570D0 (en)	1993-05-28
DE69325402D1 (de)	1999-07-29
LV12399B (en)	2000-06-20
DK0558913T3 (da)	1999-12-13
FI930906A (fi)	1993-09-03
US5262173A (en)	1993-11-16
NO930743L (no)	1993-09-03
KR930019209A (ko)	1993-10-18
HK1009930A1 (en)	1999-06-11
IL104865A (en)	1997-02-18
CA2090561A1 (en)	1993-09-03

Publication	Publication Date	Title
ZA931444B (en)	1993-10-14	Pulsatile once-a-day-delivery systems for minocycline
CA2025703A1 (en)	1991-03-22	Pulsatile once-a-day delivery systems for minocycline
US4784858A (en)	1988-11-15	Controlled release tablet
CA2140254C (en)	2004-01-20	Controlled release morphine preparation
EP0698389B1 (en)	1999-12-22	Controlled release matrix for pharmaceuticals
MY125662A (en)	2006-08-30	Pharmaceutical formulations containing darifenacin
IE970588A1 (en)	2000-08-23	Controlled release pharmaceutical compositions containing tiagabine
EP1007006B1 (en)	2003-06-25	Cefadroxil monohydrate tablet formulation
EP1140034A1 (en)	2001-10-10	Controlled release formulation of divalproex sodium
CA2383212C (en)	2008-11-25	Controlled release oral dosage suitable for oral administration
CA2180178A1 (en)	1995-07-06	Use of 2,3-diaryl-1-benzopyran derivatives for the manufacture of a medicament in the treatment and prevention of bone loss and osteoporosis
TH13279EX (th)	1993-10-13	ระบบการนำส่งไมโนไซคลีนแบบวันละครั้งเป็นจังหวะ
MY110769A (en)	1999-03-31	Controlled release oxycodone compositions.
AU2004210543A1 (en)	2004-10-07	Controlled release formulation of divalproex sodium
MY114610A (en)	2002-11-30	Controlled drug delivery system for diltiazem.
MXPA01006202A (es)	2002-05-09	Formulacion de liberacion controlada de sodio de divalproex
RU97115937A (ru)	1999-06-27	Применение изосорбид-5-мононитрата